Skip to content
Tanzania

Mefenamic Acid: Uses, Dosage, Risks and Side Effects

Mefenamic acid is a prescription nonsteroidal anti-inflammatory drug, or NSAID, used mainly for short-term relief of mild to moderate pain and menstrual cramps. It is taken by mouth in capsule form and requires careful use because the same medicine that reduces pain can also affect the stomach, kidneys, heart and other organs. Understanding the correct dosage, interactions and warning signs matters before treatment begins.

What is mefenamic acid used for?

Mefenamic acid belongs to the NSAID group of medicines. Doctors prescribe it to relieve mild to moderate pain, while it can also be used to control menstrual cramps and other conditions when clinically appropriate. The US brand name listed in the source is Ponstel.

Unlike medicines intended for continuous long-term treatment, mefenamic acid is commonly prescribed for relatively short periods. That distinction matters. Longer exposure to NSAIDs can increase the likelihood of unwanted effects, particularly in people who already have cardiovascular, kidney or gastrointestinal risk factors.

For patients in Tanzania and elsewhere in East Africa, the practical message is straightforward: familiar pain does not automatically make every painkiller interchangeable. Taking mefenamic acid alongside another NSAID, using a previous prescription without medical advice or extending treatment beyond the prescribed period can increase risk.

Mefenamic acid dosage and proper use

Mefenamic acid should be taken exactly as directed by a doctor. Patients should not increase the dose, shorten the intervals between doses or continue taking it longer than prescribed. If it causes stomach upset, the medicine may be taken with food or milk.

For the standard oral capsule formulation, the source gives the following average dosing guidance:

  • Menstrual cramps, age 14 and above: An initial dose of 500 mg, followed by 250 mg every six hours as needed, generally for two to three days.
  • Mild to moderate pain, age 14 and above: An initial dose of 500 mg, followed by 250 mg every six hours as needed, for no longer than one week.
  • Children under 14: The dose and suitability must be determined by a doctor.

These figures are general reference doses, not permission to self-prescribe. The correct amount can depend on the medicine’s strength, the condition being treated and the patient’s health.

If a dose is missed, it should be taken when remembered unless the next scheduled dose is approaching. In that situation, the missed dose should be skipped. Double dosing is not advised.

Who should use mefenamic acid with extra caution?

Medical history matters before taking this medicine.

People should tell their doctor about previous allergic reactions to mefenamic acid, aspirin, other NSAIDs or other medicines. The source also states that safety and effectiveness have not been established for children younger than 14 years in the circumstances described. Older adults may require additional caution because age-related kidney problems can influence how the medicine is used.

Extra care may be required in people with conditions including:

  • Anemia
  • Asthma
  • Bleeding disorders
  • Blood clots
  • Heart failure
  • High blood pressure
  • Kidney disease
  • Liver disease
  • Previous heart attack or stroke
  • Fluid retention
  • High potassium levels
  • Previous stomach or intestinal ulcers or bleeding

Mefenamic acid should not be used in certain patients with severe kidney disease, active stomach ulcers or a history of aspirin-sensitive asthma or sensitivity to aspirin and other NSAIDs. It should also not be used for pain immediately before or after coronary artery bypass graft surgery.

Dehydration or low blood volume also deserves attention. These conditions should be corrected before treatment according to the source.

Drug interactions patients need to consider

Mixing medicines deserves just as much attention as the dosage itself.

Mefenamic acid interacts with numerous prescription and non-prescription products. Ketorolac is specifically listed as a medicine that is not recommended for use with mefenamic acid. Other potentially significant interactions include aspirin, anticoagulants such as apixaban, several other NSAIDs, blood-pressure medicines and diuretics.

That creates a practical issue for people who buy pain medicines from different pharmacies or combine prescribed treatment with over-the-counter products. A patient may unknowingly take two drugs from the same NSAID family.

Before starting mefenamic acid, tell the doctor or pharmacist about all medicines being used, including over-the-counter painkillers, vitamins and herbal products. Alcohol, tobacco and certain foods may also affect how some medicines behave and should be discussed with a healthcare professional.

Serious risks and warning signs

Mefenamic acid can produce serious complications even when taken for legitimate medical reasons.

One major concern is cardiovascular risk. The medicine can increase the risk of heart attack, heart failure or stroke, particularly among people who already have heart disease or who use the medicine for extended periods. Warning symptoms include chest discomfort, breathing difficulty, weakness, slurred speech and pain extending to the arms, jaw, back or neck.

Gastrointestinal bleeding is another major concern. Bleeding or ulceration in the stomach or intestines can develop without much warning. Severe abdominal pain, black tarry stools or vomiting blood — including material resembling coffee grounds — requires urgent medical attention.

Kidney problems can also occur. Reduced urination, swelling, rising blood pressure, unusual tiredness, breathing problems and unexplained weight gain can signal complications requiring medical review.

Rare but severe skin reactions have been associated with the medicine, including Stevens-Johnson syndrome, toxic epidermal necrolysis and other serious drug reactions. Blistering, peeling skin, widespread rash, sores in the mouth, unusual bruising or marked weakness should not be ignored.

Anaphylaxis is another emergency risk. Trouble breathing or swallowing, swelling of the face or mouth, hoarseness, itching or a sudden rash after taking the medicine requires immediate medical attention.

Mefenamic acid side effects

Some unwanted effects are more frequently reported than others.

More common effects requiring medical attention listed in the source include nausea, indigestion, heartburn, severe stomach pain, increased blood pressure, swelling, reduced urination, unusual bleeding, difficulty breathing and vomiting. Bloody urine and black or tarry stools are also listed.

Less common effects include dizziness, headache, blurred vision, chest tightness, constipation, painful urination, irregular heartbeat, mouth inflammation, dark urine and yellowing of the eyes or skin.

Some effects may be less serious and can settle as the body adjusts. These include gas, stomach discomfort, a feeling of fullness and ringing or buzzing in the ears. Other possible effects include dry mouth, sleepiness, trouble sleeping, hair thinning, increased sensitivity to sunlight and tingling sensations.

Patients should still discuss persistent or troublesome symptoms with a healthcare professional.

Pregnancy, fertility and breastfeeding considerations

Women who are pregnant, planning a pregnancy or breastfeeding should discuss mefenamic acid with a clinician before using it.

The medicine can delay ovulation and may affect the ability to conceive while it is being used. The source also warns that taking mefenamic acid during the later part of pregnancy can harm an unborn baby.

For breastfeeding, available evidence is insufficient to clearly determine infant risk, so potential benefits and risks should be weighed with a healthcare professional.

This is especially relevant when menstrual pain treatment becomes routine. Repeatedly reaching for the same medicine without discussing pregnancy plans, fertility treatment or other reproductive considerations can overlook risks that are not immediately obvious.

How to use mefenamic acid more safely

Safe use starts with the prescription, but it does not end there.

Patients should keep an up-to-date list of every medicine and supplement they take and show it to the prescribing clinician or pharmacist. Avoid adding another painkiller without checking whether it belongs to the NSAID family. Anyone with previous ulcers, kidney disease, cardiovascular disease, high blood pressure or unusual reactions to aspirin should make that history clear before treatment begins.

Mefenamic acid should also be stored in a closed container at room temperature, protected from excessive heat, moisture and direct light, and kept out of children’s reach. Unused or expired medicine should be disposed of according to advice from a healthcare professional.

For authoritative drug information, visit the official Mayo Clinic page at:
https://www.mayoclinic.org/drugs-supplements/mefenamic-acid-oral-route/description/drg-20070790

Mefenamic acid can provide effective short-term relief from pain and menstrual cramps when used under proper medical supervision. Its benefits need to be balanced against gastrointestinal, kidney, cardiovascular, allergic and drug-interaction risks, making correct dosing and early recognition of warning signs essential to safer treatment.

Author

  • Asha Mwakalinga

    Asha Mwakalinga is a Careers & Employment Journalist at HiviSasa, where she covers recruitment, job opportunities, graduate programmes, internships, workplace trends, and career development in Tanzania. She holds a Bachelor of Journalism, with training in news writing, reporting, interviewing, media ethics, research, fact-checking, and digital journalism. Asha uses her journalism background to review official recruitment announcements, verify employment information, and explain application requirements in a clear and practical way. Her work is especially focused on helping graduates, first-time job seekers, and experienced professionals understand qualifications, deadlines, required documents, and career opportunities. She is committed to accurate reporting, responsible sourcing, and producing useful information that readers can independently verify.

About this reporter

Asha Mwakalinga

Asha Mwakalinga is a Careers & Employment Journalist at HiviSasa, where she covers recruitment, job opportunities, graduate programmes, internships, workplace trends, and career development in Tanzania. She holds a Bachelor of Journalism, with training in news writing, reporting, interviewing, media ethics, research, fact-checking, and digital journalism. Asha uses her journalism background to review official recruitment announcements, verify employment information, and explain application requirements in a clear and practical way. Her work is especially focused on helping graduates, first-time job seekers, and experienced professionals understand qualifications, deadlines, required documents, and career opportunities. She is committed to accurate reporting, responsible sourcing, and producing useful information that readers can independently verify.

More on This Story

Just In